BIOMAT Database Logo BIOMAT Database Logo

Hyperuricemia as a risk factor for cardiovascular disease. 2015

Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
2nd Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece.

UI MeSH Term Description Entries
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014527 Uric Acid An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. 2,6,8-Trihydroxypurine,Ammonium Acid Urate,Monosodium Urate,Monosodium Urate Monohydrate,Potassium Urate,Sodium Acid Urate,Sodium Acid Urate Monohydrate,Sodium Urate,Sodium Urate Monohydrate,Trioxopurine,Urate,Acid Urate, Ammonium,Acid Urate, Sodium,Acid, Uric,Monohydrate, Monosodium Urate,Monohydrate, Sodium Urate,Urate Monohydrate, Monosodium,Urate Monohydrate, Sodium,Urate, Ammonium Acid,Urate, Monosodium,Urate, Potassium,Urate, Sodium,Urate, Sodium Acid
D033461 Hyperuricemia Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.

Related Publications

Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
In response: hyperuricemia as a risk factor for cardiovascular disease.
January 2015, Expert review of cardiovascular therapy,
Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
Hyperuricemia as a risk factor for cardiovascular disease: clinical review.
November 2016, Medwave,
Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
[Hyperuricemia as a cardiovascular risk factor].
June 2001, Medicina clinica,
Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
Hyperuricemia as a risk factor for cardiovascular mortality.
January 1982, Acta medica Scandinavica. Supplementum,
Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
[Is hyperuricemia a cardiovascular risk factor?].
January 2006, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
[Hyperuricemia as a risk factor].
January 1989, Revmatologiia (Moscow, Russia),
Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
Hyperuricemia as a risk factor in coronary heart disease.
January 1977, Advances in experimental medicine and biology,
Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
Hyperuricemia and cardiovascular disease risk.
October 2014, Expert review of cardiovascular therapy,
Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
Renal disease as a risk factor for cardiovascular disease.
January 2000, Basic research in cardiology,
Niki Katsiki, and Michael Doumas, and Vasilios G Athyros, and Asterios Karagiannis
Periodontitis as a risk factor for cardiovascular disease.
February 2000, The journal of contemporary dental practice,
Copied contents to your clipboard!